Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity

v3.20.4
Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity - USD ($)
$ in Thousands
Total
Adjustment for impact of accounting standard
Series A Redeemable Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Adjustment for impact of accounting standard
Accumulated Other Comprehensive Income
Accumulated Deficit
Accumulated Deficit
Adjustment for impact of accounting standard
Preferred stock, beginning balance (in shares) at Dec. 31, 2017     6,864,000            
Preferred stock, beginning balance at Dec. 31, 2017     $ 32,615            
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Redemption of Series A Preferred stock (in shares)     (6,864,000)            
Redemption of Series A Preferred Stock $ (21,348)   $ (37,823)   $ (21,348)        
Deemed dividends on preferred stock and amortization of beneficial conversion feature (5,208)   $ 5,208   (5,208)        
Issuance of restricted stock, net of forfeitures (in shares)       62,182          
Issuance of restricted stock, net of forfeitures $ (297)       (297)        
Issuance of common stock for stock options (in shares) 1,570,211     1,553,544          
Issuance of common stock for stock options $ 8,598     $ 2 8,596        
Preferred stock, ending balance (in shares) at Dec. 31, 2018     0            
Preferred stock, ending balance at Dec. 31, 2018     $ 0            
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2017       80,462,574          
Stockholders' equity, beginning balance at Dec. 31, 2017 $ 171,962 $ 35   $ 80 194,687 $ (1,095) $ 274 $ (23,079) $ 1,130
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Common stock issuance ESPP plan (in shares) 113,503     117,146          
Common stock issuance ESPP plan $ 1,050       1,050        
Stock issuance fees and expenses (354)       (354)        
Loss on effective cash flow hedge (785)           (785)    
Issuance of common stock - Acquisition (in shares)       999,994          
Issuance of common stock - Acquisition 13,243     $ 1 13,242        
Issuance of common stock - public offering, net of underwriting discounts (in shares)       11,270,000          
Issuance of common stock - public offering, net of underwriting discounts 135,071     $ 11 135,060        
Gain on redemption of preferred stock 9,075       9,075        
Working capital adjustment related to acquisition 0                
Foreign currency translation adjustments (122)           (68) (54)  
Unrealized loss on securities, net 0                
ESPP Expense 243       243        
Stock compensation expense - options and restricted stock 6,640       6,640        
Net income (loss) 2,640             2,640  
Stockholders' equity, ending balance (in shares) at Dec. 31, 2018       94,465,440          
Stockholders' equity, ending balance at Dec. 31, 2018 320,443     $ 94 340,291   (579) (19,363)  
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Issuance of restricted stock, net of forfeitures (in shares)       168,501          
Issuance of restricted stock, net of forfeitures $ (837)       (837)        
Issuance of common stock for stock options (in shares) 2,309,451     2,054,911          
Issuance of common stock for stock options $ 9,974     $ 3 9,971        
Preferred stock, ending balance (in shares) at Dec. 31, 2019     0            
Preferred stock, ending balance at Dec. 31, 2019     $ 0            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Common stock issuance ESPP plan (in shares) 141,908     141,908          
Common stock issuance ESPP plan $ 2,332       2,332        
Stock issuance fees and expenses (263)       (263)        
Loss on effective cash flow hedge (1,039)           (1,039)    
Issuance of common stock - public offering, net of underwriting discounts (in shares)       8,050,000          
Issuance of common stock - public offering, net of underwriting discounts 160,774     $ 8 160,766        
Working capital adjustment related to acquisition (in shares)       (99,524)          
Working capital adjustment related to acquisition (1,977)       (1,977)        
Unrealized loss on securities, net 0                
ESPP Expense 609       609        
Stock compensation expense - options and restricted stock 9,386       9,386        
Net income (loss) 8,006             8,006  
Stockholders' equity, ending balance (in shares) at Dec. 31, 2019       104,781,236          
Stockholders' equity, ending balance at Dec. 31, 2019 507,408     $ 105 520,278   (1,618) (11,357)  
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Issuance of restricted stock, net of forfeitures (in shares)     0 97,478          
Issuance of restricted stock, net of forfeitures $ (1,276)       (1,276)        
Issuance of common stock for stock options (in shares) 2,310,934   0 2,306,951          
Issuance of common stock for stock options $ 18,275   $ 0 $ 2 18,273        
Preferred stock, ending balance (in shares) at Dec. 31, 2020     0            
Preferred stock, ending balance at Dec. 31, 2020     $ 0            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Common stock issuance ESPP plan (in shares) 138,309   0 138,309          
Common stock issuance ESPP plan $ 3,579       3,579        
Stock issuance fees and expenses (268)       (268)        
Loss on effective cash flow hedge (1,000)           (1,000)    
Cash flow hedge termination reclassified to earnings 2,661           2,661    
Issuance of common stock - public offering, net of underwriting discounts (in shares)       4,751,500          
Issuance of common stock - public offering, net of underwriting discounts 127,293     $ 5 127,288        
Working capital adjustment related to acquisition 0                
Unrealized loss on securities, net (33)           (33)    
ESPP Expense 875       875        
Stock compensation expense - options and restricted stock 9,337       9,337        
Equity component of Convertible Senior Notes due 2025 30,912       30,912        
Tax liability related to Convertible Senior Notes due 2025 (7,504)       (7,504)        
Convertible note debt issuance costs (137)       (137)        
Net income (loss) 4,172             4,172  
Stockholders' equity, ending balance (in shares) at Dec. 31, 2020       112,075,474          
Stockholders' equity, ending balance at Dec. 31, 2020 $ 694,294     $ 112 $ 701,357   $ 10 $ (7,185)